Circulating IGFBP2, one of the most abundant IGFBPs in serum [62], is suggested to play a role in protection against HFD-induced obesity and diabetes onset [40,41]. This evidence concerns the gene IGFBP2 and obesity due to melanocortin 4 receptor deficiency.